Factors governing the activation of adoptively transferred donor T cells infused after allogeneic bone marrow transplantation in the mouse.
about
HLA-haploidentical donor lymphocyte infusions for patients with relapsed hematologic malignancies after related HLA-haploidentical bone marrow transplantation.STAT3 signaling in CD4+ T cells is critical for the pathogenesis of chronic sclerodermatous graft-versus-host disease in a murine modelNonhematopoietic antigen blocks memory programming of alloreactive CD8+ T cells and drives their eventual exhaustion in mouse models of bone marrow transplantation.Donor CD4+ Foxp3+ regulatory T cells are necessary for posttransplantation cyclophosphamide-mediated protection against GVHD in mice.Effective posttransplant antitumor immunity is associated with TLR-stimulating nucleic acid-immunoglobulin complexes in humans.Dendritic cells and regulation of graft-versus-host disease and graft-versus-leukemia activity.Murine models of chronic graft-versus-host disease: insights and unresolved issues.Donor T cells primed on leukemia lysate-pulsed recipient APCs mediate strong graft-versus-leukemia effects across MHC barriers in full chimeras.Toll-like receptor signaling in transplantation.Combined nifuroxazide and SAT05f therapy reduces graft-versus-host disease after experimental allogeneic bone marrow transplantation.New strategies of DLI in the management of relapse of hematological malignancies after allogeneic hematopoietic SCT.Induction of Major Histocompatibility Complex-mismatched Mouse Lung Allograft Acceptance With Combined Donor Bone Marrow: Lung Transplant Using a 12-Hour Nonmyeloablative Conditioning Regimen.New interleukin-15 superagonist (IL-15SA) significantly enhances graft-versus-tumor activity.The role of antigen-presenting cells in triggering graft-versus-host disease and graft-versus-leukemia.Tissue Damage Caused by Myeloablative, but Not Non-Myeloablative, Conditioning before Allogeneic Stem Cell Transplantation Results in Dermal Macrophage Recruitment without Active T-Cell Interaction.
P2860
Q33566388-02023E31-A82D-49FE-A776-84BC836EBEEEQ34139886-F2B3872E-EC08-48C9-B227-E3A4E0A4EE7CQ34245299-E9BE083B-1615-4DDE-BF4D-D05541A96802Q34293038-E1DCC93E-E573-474F-BA05-B4D03699FE3AQ34755262-A341AFA5-3AD3-4154-82E9-B437DE86B5E1Q36014986-695F1264-AF5E-48C9-A983-D1B0A1CE7FDCQ36645730-24AAE276-879B-45B5-95DF-4B174D7CDDABQ37176587-2F483D05-9C51-4072-A519-919EF0F0CB44Q37236946-72C39B02-9173-452F-BD05-995CC8CDB722Q37603497-277B4E7A-233A-4B9E-A991-4C18B0B5BA5EQ38643400-6278A30A-9C1F-4A8C-BD32-BC46F643D294Q39176256-38705C93-0750-4417-B6E9-BA5734149A89Q41279994-E9908E8B-A421-4285-B5F6-25173453D760Q42151172-E3A721EA-F97A-4446-8406-C5634B7512F5Q55175732-5DCF9A69-8446-4705-A383-718D0D3B0FD2
P2860
Factors governing the activation of adoptively transferred donor T cells infused after allogeneic bone marrow transplantation in the mouse.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Factors governing the activati ...... transplantation in the mouse.
@ast
Factors governing the activati ...... transplantation in the mouse.
@en
type
label
Factors governing the activati ...... transplantation in the mouse.
@ast
Factors governing the activati ...... transplantation in the mouse.
@en
prefLabel
Factors governing the activati ...... transplantation in the mouse.
@ast
Factors governing the activati ...... transplantation in the mouse.
@en
P2093
P2860
P1433
P1476
Factors governing the activati ...... w transplantation in the mouse
@en
P2093
Ephraim J Fuchs
Jonathan D Powell
Karl B Bezak
Leo Luznik
Vedran Radojcic
P2860
P304
P356
10.1182/BLOOD-2006-09-048124
P407
P577
2007-01-16T00:00:00Z